Sanofi to produce synthetic antimilarial drugs
French drug maker Sanofi has announced the launch of a new commercial-scale manufacturing process to develop tons of artemisinin, the […]
Pharma
Arrhythmia drug may increase cancer risk
One of the most widely used medications to treat arrhythmias may increase the risk of developing cancer, especially in men […]
Dabur’s PE firm AHF to invest in dental chain
Asian Healthcare Fund, a private equity firm floated by DaburBSE -0.58 % Group chairman Anand Burman and former Dabur Pharma […]
Pioneer behind Polio vaccine dies at 96
Dr Hilary Koprowski, the Polish-born virologist who developed the first successful oral vaccination for polio, died this week at his […]
Delhi High Court seeks Glenmark’s response by May 22
The Delhi High Court has issued a notice to Indian pharmaceutical company Glenmark Pharmaceuticals on an appeal by the US […]
Deadline for pharma barcodes extended
The government has extended the deadline for one more year to affix barcodes on primary level packaging by pharmaceutical companies […]
Risk posed by lung nodules identified by new software
A multidisciplinary team of researchers at Mayo Clinic has developed a new software tool to noninvasively characterize pulmonary adenocarcinoma, a […]
EU introduces a black symbol to identify medicines undergoing additional monitoring
An inverted triangle will shortly appear on the inside leaflet of certain medicinal products on the EU market, following a […]
AYUSH warns homoeopathy colleges to shape up or shut down
Shape up or close down — that is the stern warning issued by the Union Ministry of Health and Family […]
Dr.Reddy’s to set up R & D centre in New Jersey
Dr. Reddys Laboratories (DRL) has announced plans to establish a research and development centre in Princeton, New Jersey. DRL has […]
Cadila Pharma to build plant at Astrakhan
Eyeing a presence in the lucrative and growing Russian market, Ahmedabad-based Cadila Pharmaceuticals is looking at investing up to […]
GlaxoSmithkline Consumer Healthcare Chairman Simon Scarff to quit
GlaxoSmithkline Consumer Healthcare’s Simon Scarff will step down as chairman effective April 30, 2013. Scarff’s expressed the desire during the […]
Price of cancer drugs to fall
Cancer drugs will cost almost 25% less if a new formula that calls for a price cap is implemented. The […]
